NEMLUVIO 30 mg/100mg (Nemolizumab-Ilto INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION) 30 mg/100mg

NEMLUVIO 30 mg/100mg is a lyophilized powder for solution, designed for subcutaneous administration. This medication is used to manage specific inflammatory conditions, offering targeted relief. Learn more about its uses and effects.

Strength

30 mg/100mg

Pack Size

1 SYRINGE in 1 CARTON (0299-6220-15) / 30 mg in 1 SYRINGE

Manufacturer / TM Owner

Galderma Laboratories, L.P.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

NEMLUVIO 30 mg/100mg is primarily used for the treatment of inflammatory conditions. It works by targeting specific pathways involved in inflammation, providing relief from symptoms associated with these conditions. Patients often seek NEMLUVIO for its potential to manage chronic inflammatory disorders effectively.

Side Effects

Common effects of NEMLUVIO 30 mg/100mg may include localized reactions at the injection site, such as redness or swelling. Some users might experience systemic effects like fatigue or mild gastrointestinal discomfort. These effects are generally mild and temporary, but consulting a healthcare provider is advisable if they persist or worsen.

Precautions & Warnings

NEMLUVIO 30 mg/100mg should be handled with care, ensuring proper storage and preparation. It is important to follow the prescribed administration guidelines to minimize the risk of adverse reactions. Patients with known allergies to any of the components should avoid using this medication.

Avoid Interactions

NEMLUVIO 30 mg/100mg may interact with other medications, particularly those that affect the immune system or inflammation pathways. Alcohol and certain supplements might also influence its effectiveness. Always inform your healthcare provider about all medications and supplements you are taking before starting NEMLUVIO.

Frequently Asked Questions

NEMLUVIO 30 mg/100mg is used to manage specific inflammatory conditions by targeting pathways involved in inflammation.

NEMLUVIO 30 mg/100mg is administered subcutaneously as a solution prepared from a lyophilized powder.

Common effects may include localized reactions at the injection site and mild systemic effects like fatigue or gastrointestinal discomfort.

NEMLUVIO 30 mg/100mg may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Precautions include proper storage, following administration guidelines, and avoiding use if allergic to any components.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.